Thought Leader Select Assists Global Biopharma in Battle Against Gram Negative Bacteria

November 14, 2013 · Leave a comment

In a recent Thought Leader Select Blog article, we detailed an engagement with a leading global biopharmaceutical company in its efforts to develop treatments for a variety of infections ranging from hospital-acquired pneumonia to urinary tract infections.

As part of the strategic engagement with Thought Leader Select, the company has asked us to help them identify and understand the skills and experiences of a global roster of leading physicians in so-called “gram negative” bacteria, a rising threat in the global hospital community.  Gram negatives, according to the Centers for Disease Control, are bacteria with built-in abilities to resist multiple drugs and most available anti-biotics.

Thought Leader Select’s work will result in a global panel of more than 250 leading experts on a variety of infections, including hospital-based infections and gram negatives.  The panel will consist of key opinion leaders with demonstrated clinical and research interests in the field, as well as experience in areas such as basic and clinical research, publishing in scientific journals, the collaborative development of treatment guidelines, and speaking to colleagues on the subject matter.  In addition, our work will show the many ways that these KOLs work independently and as networked groups of professionals working together to solve the great medical challenges of our time.

In a recent Frontline episode, ... read more »

TAGS:                                 

Biopharma Leader Chooses Thought Leader Select for KOL Initiatives in Bacterial Infections

September 26, 2013 · Leave a comment

September 26, 2013 (CHAPEL HILL, NC) A global biopharmaceutical leader recently tabbed North Carolina’s Thought Leader Select to assist the company with an upcoming slate of key opinion leader (KOL) initiatives in the area of bacterial infections.

The KOL initiatives will support a developing portfolio of intravenous treatments for certain bacterial infections.

Thought Leader Select, headquartered in Chapel Hill, provides research and consulting services to companies in the life sciences industry, including pharmaceutical, biotechnology, medical device, and diagnostics companies. These custom-tailored services support the necessary and critical industry outreach to and collaboration with leading medical experts, the health care professionals that advance treatment options and promote better public health at regional, national, and global levels.

For the engagement, Thought Leader Select’s in-house research team will identify and profile 250 key opinion leaders in the United States and around the world, with specialty focus in the area of infectious diseases.  The KOLs will have demonstrated skill and expertise in the sub-specialty area of hospital-acquired pneumonia, complicated urinary tract infections, and complicated intra-abdominal infections.

In addition to utilizing its comprehensive, deep-profiling methodology to assess the skills and experience of physicians within the infectious disease community, Thought Leader Select will also focus its work on notable young and new physicians, often called rising stars, in this area.

Thought Leader Select’s proprietary analytics on peer-to-peer interactions, a form of social network ... read more »

TAGS:                                               

Biopharma Giant Tabs Thought Leader Select for Initiatives in Companion Diagnostics for Oncology Products

July 9, 2013 · Leave a comment

July 9, 2013 (CHAPEL HILL, NC) A global biopharmaceutical leader has chosen Thought Leader Select to perform critical research and advisory work in support of key opinion leader initiatives advancing companion diagnostics for oncology medications.

Thought Leader Select, headquartered in Chapel Hill, North Carolina, provides research and consulting services to companies in the life sciences industry, including pharmaceutical, biotechnology, medical device, and diagnostics companies, as they reach out to and collaborate with leading medical experts to advance treatment options and promote better health worldwide.

For the engagement, Thought Leader Select’s in-house research team will identify and profile dozens of leading Canadian medical experts in pathology, with a focus on KOLs who have experience in developing companion diagnostics for cancer treatments. The company will also assess the top Canadian medical centers of excellence in pathology, delivering engagement plans that will drive interactions among the biopharma client company and its partners in medicine.

The client company, as it develops companion diagnostics for cancer medications, seeks understanding of the provincial reimbursement process and market access climate for such products, as well as learning the degrees to which medical centers of excellence optimize cancer treatment through the use of companion diagnostics.

Thought Leader Select’s work will combine the company’s objective, validated assessment methodology applied to the skills and experience of key opinion leaders in medicine with a series ... read more »

TAGS:                                                                           

Global Pharmas Choose Thought Leader Select as Vendor of Choice for KOL Initiatives

June 25, 2013 · Leave a comment

(CHAPEL HILL, NC) Canadian subsidiaries of a pair of top-15 global biopharmaceutical companies have appointed Thought Leader Select as their preferred research and engagement advisor for key opinion leader initiatives in multiple therapeutic areas.

Thought Leader Select, headquartered in Chapel Hill, North Carolina, provides research and advisory services to companies in the life sciences industry, including pharmaceutical, biotechnology, medical device, and diagnostics companies, as they reach out to and collaborate with leading medical experts to advance treatment options and promote better health worldwide.

Each company has approved Thought Leader Select as its preferred vendor for a variety of projects and retained advisory services centering on the work of key opinion leaders and centers of excellence in medicine.  Key opinion leaders, also known as thought leaders and key external experts, lead the medical field with their research, clinical practice, publishing in scientific journals, patient advocacy, treatment guidelines, and more. Centers of excellence include the high-impact teaching hospitals, medical schools, specialty clinics, and research foundations known for breakthrough research and cutting-edge clinical practice.

For the coming set of engagements, Thought Leader Select will profile the skills and experience of key opinion leaders in cardiology, gastroenterology, and genetics, as the projects center around treatments for heart failure, opioid-induced constipation, and a collection of rare and orphan diseases.   Known for the versatility of applications for its ... read more »

TAGS:                                                         

Canadian Pharma Chooses Thought Leader Select for COPD Key Opinion Leader Engagement Strategy

December 20, 2012 · Leave a comment

December 20, 2012 (CHAPEL HILL, NC) Thought Leader Select, a Chapel Hill, NC-based consulting firm serving the biopharmaceutical, medical device, and diagnostics industries, announces the commencement of a medical strategy engagement in pulmonology with a top Canadian biopharmaceutical company.

The company, part of a select group of global leaders in drug development for products treating chronic obstructive pulmonary disorder (COPD), approached Thought Leader Select for support with scientific advisory boards and continuing health education (CHE) initiatives across multiple Canadian provinces.  Having already worked with Thought Leader Select to form rosters of key opinion leaders in Canadian rheumatology and oncology circles, the company will formulate its panel of key experts in pulmonology by deploying Thought Leader Select’s team to assess the skills and experiences of physician specialists across the country.

Known for the versatility of applications for its in-house research, Thought Leader Select’s research group will analyze the skills and experience of these leading experts in multiple areas where they collaborate to advance the science of medicine and patient care, including basic and clinical research, scientific journal publishing, treatment guidelines, and more.

Throughout the remainder of the engagement, Thought Leader Select’s consulting team will provide strategic guidance, tactical recommendations for strengthening key opinion leader relationships in the nursing and pharmacy communities, and a suite of tools to promote collaborative work with KOLs.  Among these ... read more »

TAGS:                                                           

International Pharma Chooses Thought Leader Select for Women’s Health Initiative with Key Opinion Leaders, Centers of Excellence

November 6, 2012 · Leave a comment

November 6, 2012 (CHAPEL HILL, NC) Thought Leader Select, a Chapel Hill, NC-based consulting firm serving the biopharmaceutical, medical device, and diagnostics industries, announces the commencement of a national engagement in Canada focused on key opinion leaders and medical centers of excellence in women’s health with an international biopharmaceutical company.

The company, part of a select group of global leaders in drug development for products aimed at improving the health of women, approached Thought Leader Select for support in a variety of collaborative efforts with leading physicians and other health care professionals at leading universities, medical schools, teaching hospitals, and specialty clinics.  The key opinion leaders represent medical experts within the Canadian obstetrics and gynecology community, with areas of sub-specialty including fertility and the treatment of uterine tumors.

Known for the versatility of applications for its in-house research and analysis, Thought Leader Select’s research group will analyze the skills and experience of specialists in multiple areas where they collaborate with leading physicians and other health care professionals, including registered nurses, physician assistants, nurse practitioners, clinical pharmacists, and medical researchers, to advance the science of medicine and patient care in women’s health, including basic and clinical research, scientific journal publishing, treatment guidelines, and more.

Throughout the remainder of the engagement, Thought Leader Select’s consulting team will provide strategic guidance, tactical recommendations for strengthening collaborative ... read more »

TAGS:                                                               

Top US Pharma Chooses Thought Leader Select for Obesity Centers of Excellence Initiative

October 18, 2012 · Leave a comment

October 18, 2012 (CHAPEL HILL, NC)  Thought Leader Select, a Chapel Hill, NC-based consulting firm serving the biopharmaceutical, medical device, and diagnostics industries, announces the commencement of a national engagement focused on medical centers of excellence in obesity with a top U. S. biopharmaceutical company.

The company, part of a select group of global leaders in drug development for products treating the condition of obesity, approached Thought Leader Select for support with a variety of collaborative efforts, including medical science liaison outreach to leading universities, medical schools, teaching hospitals, and specialty clinics in this area.  Having already worked with Thought Leader Select to form rosters of key opinion leaders in endocrinology, primary care, nursing, pharmacy, and long-term care in the treatment of type I and type II diabetes and obesity, the company has now chosen Thought Leader Select to pinpoint the leading centers of excellence in the treatment of obesity in the United States.

Known for the versatility of applications for its in-house research and analysis, Thought Leader Select’s research group will assess the skills and experience of selected centers, detailing the collaborative activities of leading physicians and other health care professionals, including registered nurses, physician assistants, nurse practitioners, clinical pharmacists, and medical researchers, the people who advance the science of medicine and patient care, through basic and clinical research, scientific journal ... read more »

TAGS:                                                                                       

The Secret to Sound KOL Research—It’s Not a Data Dump

August 16, 2012 · Leave a comment

Industry Insights from Brian Castle

There are many ways that life science companies approach finding the right key opinion leaders in medicine to collaborate on next-generation treatments.

Some have the privilege of retaining staff members with decades of experience, during which they get to know the top doctors in their therapeutic area or disease state.  This do-it-yourself (“DIY”) method can be fraught with challenges, but it can also provide valuable insights through sound relationship building.

Other companies, to fill gaps in compliance or expertise within a given area, will contract with research organizations for their KOL work.  There are now over fifty companies (and counting) engaged in some form of key opinion leader identification, profiling, mapping, or engagement planning activities, and that’s not even counting the dozens of specialty medical communications agencies  and larger agencies that list medcomms as a specialty area.

Contracting with external vendors can result in great work, full of insights on the right medical professionals who can make a difference in whether a product succeeds or fails in getting in the right hands—those of patients.  But it can also result in really bad work—a data dump—that basically tells the buyer nothing.

We can define bad research quite easily—you know it when you see it. It often comes from methodologies that are suspect at first glance, those that rely upon too much ... read more »

TAGS:                                                   

Top 30 Global Biopharmaceutical Company Chooses Thought Leader Select for Blood Disorder KOL Partnership

June 14, 2012 · Leave a comment

June 14, 2012 (CHAPEL HILL, NC) Thought Leader Select, a Chapel Hill, NC-based consulting firm serving the biopharmaceutical, medical device, and diagnostics industries, announces the commencement of a global engagement in blood disorders with a top 30 global biopharmaceutical company.

The biopharmaceutical company, part of a select group of global leaders in drug development for a product in development to treat iron overload in the body, approached Thought Leader Select for support with its launch activities across multiple global markets.  To meet the strategic needs of the company’s pre-launch for a new blood disorders treatment, Thought Leader Select will deploy its in-house research group for an assessment of key opinion leaders in the area of chelation therapy.

Known for the versatility of applications for its in-house research, Thought Leader Select’s research group will analyze the skills and experience of leading specialists in the following geographic areas:

  • United States
  • Europe
  • Japan
  • Pacific Rim
  • Middle East

For the global assessment, the Thought Leader Select research group will identify 100 physicians appropriate for compliant engagement in support of drug development for blood disorders.

In the second phase of the assessment, Thought Leader Select’s in-house research group will engage in its exclusive, validated methodology of deep profiling, delivering objective assessments of the skills and experience of key opinion leaders across 14 areas where health care professionals define themselves as thought ... read more »

TAGS:                                                     

Top 10 Global Biopharmaceutical Company Tabs Thought Leader Select for Infectious Disease Partnership

April 26, 2012 · Leave a comment

April 26, 2012 (CHAPEL HILL, NC) Thought Leader Select, a Chapel Hill, NC-based consulting firm serving the biopharmaceutical, medical device, and diagnostics industries, announces the commencement of an inter-disciplinary infectious disease engagement with a top 10 global biopharmaceutical company.

The biopharmaceutical company, part of a select group of global leaders in drug development for the treatment of infectious diseases, approached Thought Leader Select for support with its development pipeline across the Canadian market.  To meet the combined strategic needs of the company’s emerging pipeline in treating conditions like HIV and Hepatitis-C, Thought Leader Select will deploy its in-house research group for a multi-disciplinary assessment of the key opinion leader community in infectious diseases.

Known for the versatility of applications for its in-house research, Thought Leader Select’s research group will analyze the skills and experience of leading specialists in the following areas:

Gastroenterology

Hepatology

Infectious Disease

Internal Medicine

For the first wave of the assessment, the Thought Leader Select research group will identify 50 physicians appropriate for compliant engagement in support of drug development for infectious diseases, across multiple Canadian provinces.

In the second phase of the assessment, Thought Leader Select’s in-house research group will engage in its exclusive, validated methodology of deep profiling, delivering objective assessments of the skills and experience of key opinion leaders across 14 areas where health care professionals define themselves as thought leaders, ... read more »

TAGS:                                                                           

Older posts »